Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: Effect of treatment with angiotensin convertase inhibitors

IUBMB Life

Volumn 49, Issue 4, 2000, Pages 303-307

  Kȩdziora Kornatowska, Kornelia Z ^a,b   Luciak, M ^a   Paszkowski, J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Military Medical University   (Poland)

Author keywords

Captopril; Catalase; Diabetes; Enalapril; Lipid peroxida tion; Oxidative stress; Superoxide dismutase

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES;

ANIMALIA; ENA;

EID: 0343090457     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540050033177     Document Type: Article

References (24)

1. Jennings, P. E., and Barnett, A. M. (1988) New approaches to the pathogenesis and treatment of diabetic microangiopathy. Diabetic Med. 5, 111-117.
2. Barnett, A. H. (1991) Pathogenesis of diabetic microangiopathy: An overview. Am. J. Med. 90(Suppl. 6A), 67-73.
3. Mogensen, C. E., and Christiansen, C. K. (1984) Predicting diabetic nephropathy in insulin-dependent patients. N. Engl. J. Med. 311, 89-93.
4. Wolf, G., and Thaiss, F. (1995) Hyperglycaemia - pathophysiological aspects at the cellular level. Nephrol. Dial. Transplant. 10, 1109-11112.
5. Ha, H., and Kim, K. H. (1995) Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. 48(Suppl. 51), 18-21.
6. Wohaieb, S. A., and Godin, D. V. (1987) Alterations in free radical tissue defense mechanisms in streptozotocin-induced diabetes in rat. Diabetes 36, 1014-1018.
7. Oberley, L. W. (1988) Free radicals and diabetes. Free Radicals Biol. Med. 5, 113-124.
8. Hartl, W. H., Jauch, K. W., Wolfe, R. R., and Schildberg, F. W. (1990) Effects of kinins on glucose metabolism in vivo. Horm. Metab. Res. Suppl. 22, 79-84.
9. Breyer, J. A. (1995) Medical management of nephropathy in type I diabetes mellitus: Current recommendations. J. Am. Sci. Nephrol. 6, 1523-1529.
10. Steffes, M. W. (1997) Glycemic control and the initiation and progression of the complications of diabetes mellitus. Kidney Int. 52(Suppl. 63), 36-39.
11. Mathiesen, E. R., Hommel, E., Giese, J., and Parving, H. H. (1991) Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. Br. Med. J. 303, 81-87.
12. Ravid, M., Savin, H., Justrin, I., Bental, T., Katz, B., and Lishner, M. (1993) Long term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann. Intern. Med. 118, 577-581.
13. Misra, H. P., and Fridovich, I. (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247, 3170-3175.
14. Beers, R., and Sizer, J. W. (1952) Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195, 133-140.
15. Placer, Z., Cushiman, Z., and Janson, B. (1966) Estimation of products of lipid peroxidation, malondialdehyde in biochemical systems. Anal. Biochem. 16, 359-364.
16. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
17. Ha, H., Yoon, S. J., and Kim, K. H. (1994) High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int. 46, 1620-1626.
18. Kawamura, N., Ookawara, T., Suzuki, K., Konishi, K., Mino, M., and Taniguchi, N. (1992) Increased glycated Cu,Zn-superoxide dismutase levels in erythrocytes of diabetics with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 74, 1352-1354.
19. Parving, H. H., Hommel, E., and Smidt, U. M. (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br. Med. J. 297, 1086-1091.
20. Stefanski, A., Amann, K., and Ritz, E. (1995) To prevent progression: ACE inhibitors, calcium antagonist or both? Nephrol. Dial. Transplant. 10, 151-153.
21. Kȩdziora-Kornatowska, K. (1999) Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidneys of diabetic rats. Clin. Chim. Acta 287, 19-27.
22. Bain, S. C., le Guen, C. A., and Lunec, J. (1991) Comparison of the free radical scavenging activity of captopril versus enalapril: A three-month in vivo study in hypertensive diabetic patients. J. Hum. Hypertens. 5, 511-515.
23. Craven, P. A., deRubertis, F. R., Kagan, V. E., Melhem, M., and Studer, R.K.(1997) Effects of supplementation with vitamin C or E on albuminuria, glomerularTGF-beta, and glomerular size in diabetes. J. Am. Soc. Nephrol. 8, 1405-1414.
24. Jain, S. K., McVie, R., Jaramillo, J. J., Palmer, M., and Smith, T. (1996) Effect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in type I diabetic patients. J. Am. Coll. Nutr. 15, 458-461.